|
Thalia S. Field, MD
(University of British Columbia)
|
Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Field has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Canadian Medical Protective Association, plaintiff. The institution of Dr. Field has received research support from Heart and Stroke Foundation, Brain Canada and CIHR. Dr. Field has a non-compensated relationship as a Editorial board with Stroke that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Editorial board with CJNS that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Editorial board with JNNP that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Board member with DESTINE Health that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Board Member with Vancouver General Hospital Foundation that is relevant to AAN interests or activities. |